Delivery Order W81K0220D0003-W81K0221F0123
Award Date
10/1/21
Potential Completion Date
9/30/22
Potential Value
$31K
Federal Agency
Medical Command
Awardee
Inseonmedics Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South Korea
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Inseonmedics Inc. was awarded a $20,305 firm-fixed price delivery order against its single-award indefinite delivery contract with the Defense Health Agency to supply VENTANA HE600 reagents for use at the Brian D. Allgood Army Community Hospital laboratory and Biological Defense Automated Analytical Platform in South Korea. The contract, valued at up to $649,470, provides VENTANA HE600 reagents compatible with immunohistochemistry staining platforms to support medical and biological defense...
The Department of the Army Medical Command awarded a $32,650 firm fixed-price delivery order to Inseonmedics Inc. of South Korea under a blanket purchase agreement for reagents to support the VENTANA HE600 immunohistochemistry staining platform. The reagents will support the U.S. military's laboratory in BDAACH, Korea and must be delivered by September 30, 2020. No set-aside provision was applied to this order to fulfill testing requirements at the Army medical facility in the Republic of...
This is a firm-fixed-price delivery order contract awarded by the Defense Health Agency to Inseonmedics Inc., a for-profit corporation registered in SAM.gov. The contract, valued at $12,597.00, is for the supply of VENTANA HE600 reagents to support the Brian D. Allgood Army Community Hospital and Biological Defense Automated Analytical Platform in South Korea from October 1, 2023, through September 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDV) with a...
The U.S. Defense Health Agency awarded a firm-fixed-price purchase order contract worth $121,790.00 to Inseonmedics Inc., a for-profit corporation that specializes in providing specialized medical reagents for diagnostic and laboratory purposes. The contract, which has a period of performance from October 1, 2024 to September 30, 2029, is for the procurement of VENTANA HE600 reagents to support the Brian D. Allgood Army Community Hospital laboratory and Biological Defense Automated Analytical...
This is a federal contract award from the Defense Health Agency (DHA) to Inseonmedics Inc., a for-profit corporation registered in SAM.gov. The contract, identified as W81K0220D0003|W81K0224F0054, is for the delivery of VENTANA HE600 reagents, which are critical consumables used in immunohistochemistry staining platforms to support military healthcare and biological defense programs at U.S. military medical facilities in South Korea. The contract is a delivery order under an Indefinite...
This is a firm fixed price delivery order awarded to Chenkwang Science, a for-profit South Korean company, by the Defense Health Agency. The $46,068.75 order is for the delivery of Biomerieux reagents to support clinical diagnostic testing for bacterial pathogens and antimicrobial resistance at U.S. military hospitals in South Korea and Japan. Chenkwang Science is an established federal contractor, holding at least three indefinite delivery contracts with the Department of Defense to provide...
This is a firm fixed price delivery order awarded by the Defense Health Agency (DHA) to Chenkwang Science, a for-profit organization based in South Korea. The $22,774.50 contract is for the delivery of Biomerieux reagents to support biological defense analytical capabilities at U.S. military medical treatment facilities in South Korea, such as Brian Allgood Army Community Hospital and the United States Naval Hospital in Okinawa, Japan. The order has an ultimate completion date of September 30,...
Chenkwang Science has been awarded a $23,121 firm fixed price delivery order by the Defense Health Agency to provide Biomerieux reagents for biological defense analytical and assessment activities in Korea through September 2024. The reagents will support the agency's Biological Defense Analytical and Assessment Center in Korea under Chenkwang Science's existing indefinite delivery contract valued at $232,645 over five years. No set-aside designation was applied to this order. Chenkwang...
The Department of the Army Medical Command awarded a $600,000 firm fixed price delivery order to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch. This order is issued under an existing contract vehicle to provide reagents including diagnostics chemistry and immunology analyzers for use at Camp Humphreys in South Korea. The prime contractor will deliver the requested medical products and equipment from October 2021 through September 2022 to support the Army's healthcare operations. No...
This is a delivery order for Option Year 3 of a contract awarded by the Department of the Army Medical Command to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch, a for-profit medical equipment manufacturer, to provide chemistry and immunology reagents. The total potential value of this delivery order is $410,765.22. This order falls under a larger indefinite-delivery indefinite-quantity (IDIQ) contract vehicle held by Ortho-Clinical Diagnostics Singapore with the Department of the...